
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145946310.1021/acsomega.8b02132ArticleOrganocatalytic Enantioselective Mannich Reaction:
Direct Access to Chiral β-Amino Esters Ravi Kumar G. †Ramesh Boora †Yarlagadda Suresh †Sridhar Balasubramanian ‡Reddy B. V. Subba *††Fluoro & Agrochemicals and ‡Laboratory of X-ray Crystallography, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India* E-mail: basireddy@iict.res.in. Fax: 91-40-27160512.29 01 2019 31 01 2019 4 1 2168 2177 24 08 2018 11 01 2019 Copyright © 2019 American Chemical
Society2019American Chemical
SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

An asymmetric Mannich reaction has
been developed to generate chiral
β-amino esters in good yields with excellent enantiomeric excesses
(ee, up to 99%) using a chiral bifunctional thiourea catalyst derived
from (R,R)-cyclohexyldiamine. This
is the first report on the addition of 3-indolinone-2-carboxylates
to N-Boc-benzaldimines generated in situ from α-amidosulfones,
which proceeds under mild conditions.

document-id-old-9ao8b02132document-id-new-14ao-2018-02132vccc-price
==== Body
Introduction
Chiral
ß-amino esters are useful building blocks for the synthesis
of ß-lactams and unnatural peptides.1 They found widespread applications in drug discovery.2 On the other hand, a chiral 2,2-disubstituted
indolin-3-one skeleton3 is often present
in several biologically active natural products such as (+)-isatisine
A, trigonoliimine C, mersicarpine, etc.4,5 They are known
to exhibit potent antiviral properties.6 Consequently, a few methods have been reported for the enantioselective
conversion of 3-indolinone-2-carboxylates into chiral compounds.7 However, the construction of a chiral quaternary
stereocenter is a challenging task for a synthetic chemist.8 Furthermore, an asymmetric Mannich reaction is
a powerful strategy to produce chiral ß-amino ketones and ß-amino
esters.9 Inspired by their fascinating
structural features and potent biological activities, we were interested
in producing chiral 2,2-disubstituted indolin-3-one derivatives. Indeed,
there are no reports on the direct asymmetric Mannich-type addition
of 3-indolinone-2-carboxylates to N-Boc-benzaldimines
generated in situ from α-amidosulfones Figure 1.

Figure 1 Examples of 3-indolinone natural products.

Following our interest in asymmetric
synthesis,10 we herein report an enantioselective
Mannich reaction of
2-substituted indolin-3-ones for the synthesis of chiral β-amino
esters, using a thiourea catalyst derived from trans-(R,R)-1,2-diaminocyclohexane.
Our investigation began with the reaction of 3-indolinone-2-carboxylate
(1) with N-Boc-benzaldimine (2) using quinidine 4a as a catalyst in the presence of
Na2CO3 in toluene (Table 1, entry a) at room temperature. Interestingly,
the desired product 3a was obtained in 60% yield with
10% enantiomeric excesses (ee) and 92:8 diastereoselectivity. Next,
we attempted the same reaction with dihydroquinidine 4b as a catalyst, and no significant improvement in yield and ee of
product 3a was observed. Furthermore, the reaction was
performed using a bifuntional Takemoto’s catalyst 4c, 5 mol %, and Na2CO3 in toluene at room temperature.
Interestingly, the desired product 3a was obtained in
80% yield with 55% ee and 93:7 diastereoselectivity (Table 1, entry c). To enhance the enantio-
and diastereoselectivity, the reaction was further performed with
5 mol % catalyst 4d under similar conditions (Table 1, entry d). A slight
improvement was observed in enantio- and diastereoselectivity. Therefore,
the reaction was further performed using a 5 mol % catalyst 4e under identical conditions. To our delight, the yield and
ee were improved significantly (Table 1, entry e). To evaluate other thiourea catalysts (Scheme 1), the reaction was
further carried out using a 5 mol % bis-thiourea catalyst 4f derived from trans-(R,R)-1,2-diaminocyclohexane. However, the product 3a was obtained with low enantio- and diastereoselectivity. To improve
the enantio- and diastereoselectivity, the reaction was repeated using
5 mol % thiourea catalysts 4g and 4h derived
from trans-1,2-diaminoindane and trans-1-amino-2-indanol, respectively. The desired product 3a was obtained in poor yield and with low selectivity (Table S1, entries g and h). Therefore, the next
reaction was carried out using a thiourea catalyst 4i derived from 1,1′-binaphthyl-2,2′-diamine (Table 1, entry i). However,
the catalyst 4i was found to be inferior than other catalysts.
To know the effect of base, the reaction was conducted in toluene
using different bases like Na2CO3, K2CO3, Cs2CO3, NaOH, and CsOH (Table 1, entries i–m).
Among them, Na2CO3 in toluene was found to be
the best for this transformation (Table 1, entry m). To our surprise, only 30% conversion
was observed using 10% Na2CO3 solution and 60%
conversion was observed with 50% Na2CO3 solution.
Interestingly, 98% conversion was obtained with a sat. Na2CO3 solution, which was prepared using 32 g of Na2CO3 in 100 mL of water at 27 °C. Furthermore,
we examined the effect of different solvents such as o-xylene, methyl tert-butyl ether, benzene, and dichloroethane
on the conversion under similar reaction conditions (Table 1, entries n–r). None
of these solvents produced better results than o-xylene
(Table 1, entry n).
Finally, we tested the effect of temperature, ranging from 25 to −78
°C, on the conversion. The best results were obtained using 5
mol % catalyst 4e and Na2CO3 in
xylene at 0 °C. Due to the low freezing point of xylene (−25
°C), further reactions were conducted in toluene. However, there
was no reaction in toluene at −78 °C under similar conditions
(Table 1, entry u).

Scheme 1 Catalyst Screening in the Asymmetric Mannich Reaction
Table 1 Optimization of Reaction Conditions
in the Formation of 3aa
entry	catalyst	base (aq.)	solvent T (°C)	time (days)	yield (%)b	dr (3a:3aa)c	ee (%)c	entry	catalyst	base (aq.)	solvent	T (°C)	time (days)	yield (%)b	dr (3a:3aa)c	ee (%)d,e	
a	4a	Na2CO3	toluene 25	3	45	92:8	10	l	4e	NaOH	toluene	25	1	20	90:10	5	
b	4b	Na2CO3	toluene 25	2	60	93:7	5	m	4e	CsOH	toluene	25	1	25	95:5	10	
c	4c	Na2CO3	toluene 25	4	80	93:7	55	n	4e	Na2CO3	xylene	0	3	98	99:1	99	
d	4d	Na2CO3	toluene 25	3	85	98:2	60	o	4e	Na2CO3	toluene	0	3	60	99:1	65	
e	4e	Na2CO3	toluene 25	2	90	99:1	85	p	4e	Na2CO3	MTBE	0	3	50	99:1	30	
f	4f	Na2CO3	toluene 25	4	40	95:5	50	q	4e	Na2CO3	benzene	0	3	55	99:1	40	
g	4g	Na2CO3	toluene 25	5	45	89:11	30	r	4e	Na2CO3	DCE	0	3	35	99:1	20	
h	4h	Na2CO3	toluene 25	4	50	88:22	25	s	4e	Na2CO3	xylene	–20	4	35	99:1	40	
i	4i	Na2CO3	toluene 25	5	40	90:10	30	t	4e	Na2CO3	toluene	–40	5	30	99:1	30	
j	4e	K2CO3	toluene 25	2	80	99:1	70	u	4e	Na2CO3	toluene	–78	2	 	 	 	
k	4e	Cs2CO3	toluene 25	2	65	95:5	20	 	 	 	 	 	 	 	 	 	
a All reactions were performed at
0.21 mmol of 1, 0.25 mmol of 2, 5 mol % 4e and 0.2 mL of aqueous base in 5 mL of solvent.

b Isolated yields after column chromatography.

c Diastereomeric ratio was determined
by 1H NMR.

d Enantiomeric
excess was determined
by chiral high-performance liquid chromatography (HPLC).

e Enantiomeric ratio of the major
diastereomer.

After having
optimized conditions in hand, the scope of this method
was examined with different substrates, and the results are summarized
in Table 2. The substituent
present on the aromatic ring of aldimine had shown some effect on
the conversion. Ortho- and meta-substituted benzaldimines afforded
the corresponding product in excellent yield with excellent enantioselectivity
(Table 2, entries 3b, 3c, 3i, and 3k).
The substrate bearing electron-withdrawing substituents such as nitro-
and cyano- on the aromatic ring of aldimine gave the desired product
in high yield with excellent enantiomeric excess (Table 2, entries 3h, 3i, 3j, and 3k). Conversely, the
substrate having electron-donating groups like methyl- and methoxy
on the aromatic ring gave the product with low ee (Table 2, entries 3f and 3g). Next, we examined the effect of substituents that are
present at the 5th position of methyl 3-oxoindoline-2-carboxylate.
The desired products were obtained in good yields but with low ee
(Table 2, entries 3o, 3p, and 3q). The scope of this
process was further extended to polyaromatic and heterocyclic systems.
Interestingly, the aldimines derived from heteroaromatic aldehydes
gave the products in excellent yield with excellent enantiomeric excess
(Table 2, entries 3m and 3r). Furthermore, a sterically hindered
naphthyl derivative also gave the desired product in good yield with
excellent selectivity (Table 2, entry 3s). In addition, we have screened the
N-substituted 3-oxo-indoline-2-carboxylate; in this, free NH and N-phenyl-substituted substrates failed to give the product,
whereas the N-benzoyl 3-oxo-indoline-2-carboxylate
participated smoothly in the present reaction and afforded the corresponding
product (Table 2, entry 3n) in good yield and with excellent enantio- and diastereoselectivity.
However, a slight decrease in the enantioselectivity was observed
in the case of N-benzoyl 3-oxo-indoline-2-carboxylate
(Table 2, entry 3n) compared to that of N-acetyl 3-oxo-indoline-2-carboxylate
(Table 2, entry 3c).

Table 2 Substrate Scopea
a All reactions
were performed at
0.21 mmol of 1, 0.25 mmol of 2, 5 mol % 4e, and 0.2 mL of aqueous base in 5 mL of solvent.

b Isolated yields after column chromatography.

c Diastereomeric ratio was determined
by 1H NMR.

d Enantiomeric
excess was determined
by chiral HPLC.

e Enantiomeric
ratio of the major
diastereomer.

According
to X-ray crystallography (CCDC 1842015), the structure
and relative configuration of 3h were determined (Figure 2).11

Figure 2 Oak Ridge thermal-ellipsoid plot program (ORTEP) diagram of 3h.

The absolute stereochemistry
was established by single-crystal
X-ray crystallography of 3t, which is having heavy atoms
in its structure (Figure 3).11 As depicted in the ORTEP diagram,
the absolute stereochemistry of 3t was assigned as R,S.

Figure 3 ORTEP diagram of 3t.

Finally, we tried to convert the
product 3a into a
spirolactam to demonstrate its synthetic application. To our surprise,
the compound 3a failed to undergo cyclization under basic
conditions (Scheme 2).

Scheme 2 Spirolactam Formation
Mechanistically, the reaction proceeds through the formation
of
an enolate ion from 3-indolinone-2-carboxylate 3a by
a tertiary amine moiety of the ligand 4e through deprotonation.
A subsequent activation of N-Boc-benzaldimine by
a thiourea moiety of the ligand 4e through hydrogen bonding
generates a ternary complex, which is shown in Figure S3. A preferential Re-face attack
of the enolate formed from 3-indolinone-2-carboxylate onto N-Boc-benzaldimine would give the desired product 3a, Figure 4.

Figure 4 Plausible transition state.

Conclusions
In summary, we have successfully developed an
organocatalytic asymmetric
Mannich reaction for the synthesis of chiral β-amino esters,
which are key intermediates for the synthesis of biologically active
molecules. The reaction proceeds under mild conditions and is compatible
with diverse range of substituents that are present on the aromatic
ring of aldimines. This method works with a wide range of substrates
including aryl, naphthyl, and heteroaryl cyclic ß-ketoesters.

General
Methods
All solvents were dried according to standard literature
procedures.
The reactions were conducted under a nitrogen atmosphere. Melting
points (mp) were obtained on Buchi B-540. 1H and 13C NMR (proton-decoupled) spectra were recorded in the CDCl3 solvent at 300, 400, or 500 MHz on an NMR spectrometer. Chemical
shifts (δ) were reported in parts per million (ppm) with respect
to tetramethylsilane as an internal standard. Coupling constants (J) are quoted in hertz (Hz). Mass spectra and high-resolution
mass spectrometry (HRMS) were recorded on a mass spectrometer by the
electrospray ionization (ESI) or atmospheric pressure chemical ionization
technique. Optical rotations were recorded on an Anton Paar MCP-200
polarimeter. Enantiomeric excesses (ee’s) were determined by
HPLC analysis using DAICEL Chiralpak OD-H, AS-H, IC, IA columns. The
precursors were prepared according to the procedure reported in the
literature.12

General Procedure for the
Asymmetric Mannich Reaction (3a)
To a suspension of 2-substituted
3-indolinones 11 (50 mg, 1.0 equiv, 0.21 mmol
%) and α-amidosulfones 22 (1.2 equiv,
0.25 mmol %) in xylene (5 mL) at
0 °C were added catalyst 4c3 (5 mol %)
and saturated Na2CO3 (0.2 mL) successively.
The resulting mixture was stirred for 3 days at 0 °C and then
with water and extracted with ethyl acetate. The organic layer was
dried over Na2SO4 and concentrated under vacuum
to give the crude product, which was purified by column chromatography
using a gradient mixture of ethyl acetate/hexane (2:8) as the eluent
to afford the product 3a.

All other reactions were
carried out according to the general procedure for the synthesis of 3a to 3s. The racemic samples were prepared by
the following general procedure, using quinine and quinidine (1:1)
as catalysts instead of thiourea 4c. In the absence of
quinine and quinidine, the racemic reaction was very sluggish and
takes more than 5 days for the completion with low yield.

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(phenyl)methyl)-3-oxoindoline-2-carboxylate
(3a)
(0.084 g, 92% yield) white solid. Mp 130–132
°C. IR (neat) ν 3409.7, 3007.4, 2978.2, 1763.6, 1706.2,
1476.0, 1339.9, 1291.4, 1164.4, 1048.1, 770.8, 693.3 cm–1. 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 7.2 Hz, 1H), 7.50–7.41 (m, 1H), 7.10 (t, J = 7.5 Hz, 1H), 6.98 (s, 6H), 6.70 (s, 1H), 5.97 (s, 1H),
3.76 (s, 3H), 2.38 (s, 3H), 1.45 (s, 9H). 13C NMR (100
MHz, CDCl3) δ 194.5, 167.8, 165.2, 155.2, 137.8,
127.8, 127.6, 126.9, 126.6, 124.8, 124.0, 114.5, 79.5, 74.4, 55.9,
53.4, 28.4, 25.6. HRMS (Orbitrap ESI): exact mass calcd for C24H26N2O6Na [M + Na]+: 461.1683. Found: 461.1696. HPLC analysis (DAICEL Chiralpak OD-H), n-hexane/2-PrOH = 80:20, 1 mL/min, 254 nm, major (7.23 min),
minor (8.50 min), ee: 97.25; [α]D20 −40.2 (c =
0.15, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-(2-bromophenyl)((tert-butoxycarbonyl)amino)methyl)-3-oxoindoline-2-carboxylate
(3b)
(0.106 g, 96% yield) white solid. Mp 130–132
°C. IR (neat) ν 3415.7, 3007.5, 2978.3, 1765.0, 1706.8,
1607.1, 1499.7, 1470.3, 1333.3, 1266.2, 1166.0, 971.1, 770.9, 609.2
cm–1. 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 5.6 Hz, 1H), 7.47 (t, J = 7.4 Hz, 1H), 7.32 (s, 1H), 7.2–6.9 (m, 3H), 6.83
(s, 2H), 6.63 (s, 1H), 6.30 (s, 1H), 3.76 (s, 3H), 2.47 (s, 3H), 1.44
(s, 9H). 13C NMR (101 MHz, CDCl3) δ 194.9,
168.2, 165.4, 155.0, 152.7, 137.6, 132.6, 129.3, 129.1, 126.5, 124.9,
124.2, 114.9, 79.7, 74.3, 55.3, 53.2, 28.4, 25.7. HRMS (Orbitrap ESI):
exact mass calcd for C24H25N2O6BrNa [M + Na]+: 539.0788. Found: 539.0810. HPLC
analysis (DAICEL Chiralpak AS-H), n-hexane/2-PrOH
= 85:15, 1 mL/min, minor (11.55 min), ee: 96.83; [α]D20 −88 (c = 0.15, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(3-chlorophenyl)methyl)-3-oxoindoline-2-carboxylate
(3c)
(0.099 g, 98% yield) white solid. Mp 130–132
°C. IR (neat) ν 3411.1, 3011.5, 2978.1, 1761.6, 1716.1,
1606.7, 1500.1, 1434.3, 1374.2, 1334.2, 1265.9, 1165.6, 761.5, 614.5
cm–1. 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 7.5 Hz, 1H), 7.53–7.48
(m, 1H), 7.14 (t, J = 7.5 Hz, 1H), 7.02–6.84
(m, 5H), 6.69 (s, 1H), 5.94 (s, 1H), 3.76 (s, 3H), 2.41 (s, 3H), 1.46
(s, 9H). 13C NMR (101 MHz,) δ 194.1, 167.8, 165.0,
155.2, 152.0, 139.5, 138.0, 133.6, 128.9, 128.0, 127.3, 125.4, 125.0,
124.2, 114.5, 79.8, 74.0, 55.4, 53.4, 28.4, 25.6. HRMS (Orbitrap ESI):
exact mass calcd for C24H25N2O6ClNa [M + Na]+: 495.1293. Found: 495.1312. HPLC
analysis (DAICEL Chiralpak AS-H), n-hexane/2-PrOH
= 80:20, 1 mL/min, 254 nm, major (5.58 min), minor (8.8 min), ee:
98.90; [α]D20 −61 (c = 0.5, CHCl3).

Methyl
(R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(4-fluorophenyl)methyl)-3-oxoindoline-2-carboxylate
(3d)
(0.086 g, 88% yield) white solid. Mp 135–137
°C. IR (neat) ν 3410.5, 3010.5, 2979.8, 1764.5, 1707.2,
1606.5, 1471.9, 1371.4, 1324.3, 1238.3, 1164.1, 1065.5, 752.8, 619.1
cm–1. 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 5.6 Hz, 1H), 7.47 (t, J = 7.4 Hz, 1H), 7.32 (s, 1H), 7.08–6.91 (m, 3H),
6.83 (s, 2H), 6.63 (s, 1H), 6.30 (s, 1H), 3.76 (s, 3H), 2.47 (s, 3H),
1.44 (s, 9H). 13C NMR (101 MHz, CDCl3) δ
194.5, 167.8, 165.3, 155.2, 140.6, 140.4, 137.8, 132.9, 130.3, 128.7,
127.4, 127.3, 126.8, 126.3, 124.8, 124.0, 114.7, 79.6, 55.7, 53.4,
28.4, 25.6. HRMS (Orbitrap ESI): exact mass calcd for C24H25N2O6FNa [M + Na]+:
479.1588. Found: 479.1605. HPLC analysis (DAICEL Chiralpak IC), n-hexane/2-PrOH = 80:20, 1 mL/min, 254 nm major (6.24 min),
minor (9.40 min), 96.97; [α]D20 −74 (c = 0.1, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(4-chloro-2-fluorophenyl)methyl)-3-oxoindoline-2-carboxylate
(3e)
(0.096 g, 92% yield) white solid. Mp 170–172
°C. IR (neat) ν 3410.7, 3032.4, 2956.5, 1760.4, 1728.9,
1684.5, 1606.2, 1463.5, 1376.2, 1339.6, 1297.6, 1155.0, 1093.9, 759.9,
647.7 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 7.4 Hz, 1H), 7.54–7.46
(m, 1H), 7.14 (t, J = 7.5 Hz, 1H), 7.00–6.84
(m, 4H), 6.69 (s, 1H), 5.95 (s, 1H), 3.76 (s, 3H), 2.41 (s, 3H), 1.46
(s, 9H). 13C NMR (101 MHz, CDCl3) δ 194.5,
191.9, 167.9, 165.3, 155.2, 140.6, 140.4, 137.8, 128.7, 127.4, 126.8,
126.3, 124.8, 124.0, 114.7, 79.6, 74.4, 55.7, 53.4, 28.4, 25.7. HRMS
(Orbitrap ESI): exact mass calcd for C24H24ClFN2O6Na [M + Na]+: 513.1198. Found: 513.1225.
HPLC analysis (DAICEL Chiralpak AS-H), n-hexane/2-PrOH
= 80:20, 1 mL/min, 254 nm, major (5.02 min), minor (6.83 min), ee:
88.65; [α]D20 −34.2 (c = 0.15, CHCl3).

Methyl
(R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(p-tolyl)methyl)-3-oxoindoline-2-carboxylate
(3f)
(0.077 g, 80% yield) white solid. Mp 147–149
°C. IR (neat) ν 3399.8, 3021.3, 2969.8, 1735.6, 1710.6,
1680.3, 1585.6, 1465.8, 1369.7, 1322.5, 1165.6, 1029.5, 765.6, 660.7
cm–1. 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 6.6 Hz, 1H), 7.47 (t, J = 7.8 Hz, 1H), 7.11 (t, J = 7.4 Hz, 1H),
6.81–6.74 (m, 5H), 6.66 (s, 1H), 5.93 (s, 1H), 3.76 (s, 3H),
2.38 (s, 3H), 2.12 (s, 3H), 1.45 (s, 9H). 13C NMR (101
MHz) δ 194.6, 167.8, 165.3, 155.1, 152.1, 137.7, 137.4, 134.2,
128.3, 126.8, 124.8, 123.9, 114.5, 79.4, 74.5, 55.6, 53.3, 28.4, 25.6,
20.9. HRMS (Orbitrap ESI): exact mass calcd for C25H28N2O6Na [M + Na]+: 475.1839.
Found: 475.1850. HPLC analysis (DAICEL Chiralpak OD-H), n-hexane/2-PrOH = 80:20, 1 mL/min, 254 nm, major (4.88 min), minor
(6.09 min), ee: 66.97; [α]D20 −49 (c = 0.15, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(3,4-dimethoxyphenyl)methyl)-3-oxoindoline-2-carboxylate
(3g)
(0.102 g, 96% yield) white solid. Mp 130–132
°C. IR (neat) ν 3411.5, 2956.9, 2924.1, 1785.7, 1727.3,
1689.1, 1589.4, 1464.7, 1379.9, 1345.6, 1224.7, 1155.1, 770.9 cm–1. 1H NMR (500 MHz, CDCl3) 1H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 7.3 Hz, 1H), 7.51 (ddd, J = 8.6, 7.3,
1.4 Hz, 1H), 7.14 (t, J = 7.5 Hz, 2H), 6.67 (d, J = 5.3 Hz, 1H), 6.14–6.09 (m, 3H), 5.92 (s, 1H),
3.76 (s, 3H), 3.55 (s, 6H), 2.39 (s, 3H), 1.47 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 13C NMR (101
MHz, 3>) δ 194.6, 191.9, 167.7, 165.2, 160.1, 155.2, 152.1,
139.6, 137.9, 124.7, 124.0, 114.7, 107.1, 105.0, 100.4, 79.6, 74.2,
56.10, 55.0, 53.4, 28.4, 28.2, 25.7. HRMS (Orbitrap ESI): exact mass
calcd for C26H30N2O8Na
[M + Na]+: 521.1894. Found: 521.1910. HPLC analysis (DAICEL
Chiralpak OD-H), n-hexane/2-PrOH = 80:20, 1 mL/min,
254 nm, major (6.67 min), minor (11.68 min), ee: 82.73; [α]D20 −17 (c = 0.1, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(4-nitrophenyl)methyl)-3-oxoindoline-2-carboxylate
(3h)
(0.091 g, 88% yield) yellow solid. Mp 158–160
°C. IR (neat) ν 3409.5, 3079.5, 2979.0, 1763.8, 1708.0,
1606.1, 1523.3, 1498.6, 1471.6, 1344.8, 1237.7, 1163.4, 1027.7, 752.3,
611.6 cm–1. 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.7 Hz, 2H), 7.74
(d, J = 7.6 Hz, 1H), 7.54–7.49 (m, 1H), 7.18
(m, 4H), 6.81 (s, 1H), 6.08 (d, J = 4.9 Hz, 1H),
3.77 (s, 3H), 2.42 (s, 3H), 1.44 (s, 9H). 13C NMR (101
MHz, CDCl3) δ 193.7, 168.0, 164.7, 155.2, 151.8,
147.4, 145.1, 138.4, 128.0, 125.2, 124.6, 124.3, 122.9, 114.7, 80.1,
73.7, 55.7, 53.6, 28.3, 25.6. HRMS (Orbitrap ESI): exact mass calcd
for C24H25N3O8Na [M +
Na]+: 506.1533. Found: 506.1553. HPLC analysis (DAICEL
Chiralpak AS-H), n-hexane/2-PrOH = 80:20, 1 mL/min,
254 nm major (12.60 min), minor (19.34 min), ee: 95.63; [α]D20 −57.5
(c = 0.5, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(2-nitrophenyl)methyl)-3-oxoindoline-2-carboxylate
(3i)
(0.093 g, 90% yield) yellow solid. Mp 160–162
°C. IR (neat) ν 3409.9, 3076.2, 2978.1, 1764.6, 1706.8,
1606.5, 1525.1, 1499.5, 1470.1, 1343.2, 1235.2, 1165.2, 1022.6, 759.3,
615.2 cm–1. 1H NMR (400 MHz, CDCl3) δ 7.60–7.49 (m, 3H), 7.41 (s, 1H), 7.21–7.10
(m, 4H), 6.65 (s, 2H), 3.73 (s, 3H), 2.43 (s, 3H), 1.46 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 194.0, 168.45,
165.2, 155.1, 152.2, 149.5, 137.6, 131.7, 131.4, 130.0, 128.6, 124.8,
124.5, 124.1, 116.1, 80.1, 7.6, 53.4, 52.0, 28.3, 24.7. HRMS (Orbitrap
ESI): exact mass calcd for C24H25N3O8Na [M + Na]+: 506.1533. Found: 506.1551.
HPLC analysis (DAICEL Chiralpak AS-H), n-hexane/2-PrOH
= 80:20, 1 mL/min, 254 nm, major (10.19 min), minor (12.78 min), ee:
91.21; [α]D20 −52.3 (c = 0.15, CHCl3).

Methyl
(R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(4-cyanophenyl)methyl)-3-oxoindoline-2-carboxylate
(3j)
(0.087 g, 90% yield) yellow solid. Mp 156–158
°C. IR (neat) ν 3401.6, 3009.8, 2978.9, 2230.1, 1763.7,
1707.8, 1676.5, 1606.3, 1499.8, 1417.3, 1339.5, 1239.2, 1164.2, 1025.6,
754.7, 615.6 cm–1. 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 7.5 Hz, 1H), 7.54
(ddd, J = 8.6, 7.4, 1.4 Hz, 1H), 7.31 (d, J = 8.2 Hz, 2H), 7.20–7.09 (m, 4H), 6.77 (s, 1H),
6.01 (s, 1H), 3.76 (s, 3H), 2.40 (s, 3H), 1.44 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 193.8, 168.0, 164.8, 155.2,
151.9, 143.0, 138.4, 131.5, 127.8, 125.1, 124.5, 118.3, 114.7, 111.7,
80.0, 73.7, 55.8, 53.6, 28.3, 25.6. HRMS (Orbitrap ESI): exact mass
calcd for C25H25N3O6Na
[M + Na]+: 486.1635. Found: 486.1645. HPLC analysis (DAICEL
Chiralpak OD-H), n-hexane/2-PrOH = 80:20, 1 mL/min,
254 nm, major (12.27 min), minor (16.12 min), ee: 97.63; [α]D20 −68.5
(c = 0.5, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(2-cyanophenyl)methyl)-3-oxoindoline-2-carboxylate
(3k)
(0.091 g, 90% yield) yellow solid. Mp 162–164
°C. IR (neat) ν 3404.0, 3008.5, 2978.5, 2230.8, 1763.7,
1708.6, 1677.2, 1606.6, 1472.2, 1340.1, 1241.1, 1165.4, 1025.9, 758.2,
616.5 cm–1. 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 7.6 Hz, 1H), 7.54
(ddd, J = 8.6, 7.3, 1.4 Hz, 1H), 7.31 (d, J = 8.3 Hz, 2H), 7.20–7.08 (m, 4H), 6.77 (s, 1H),
6.01 (s, 1H), 3.76 (s, 3H), 2.40 (s, 3H), 1.44 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 193.7, 168.0, 164.7, 155.2,
151.9, 143.1, 138.4, 131.5, 127.8, 125.1, 124.5, 118.3, 114.7, 111.7,
80.0, 73.7, 55.8, 53.6, 28.3, 25.6. HRMS (Orbitrap ESI): exact mass
calcd for C25H25N3O6Na
[M + Na]+: 486.1635. Found: 486.1640. HPLC analysis (DAICEL
Chiralpak AS-H), n-hexane/2-PrOH = 80:20, 1 mL/min,
254 nm, major (9.99 min), minor (10.98 min), ee: 97.76; [α]D20 −79.8
(c = 0.5, CHCl3).

Methyl (R)-2-((S)-[1,1′-Biphenyl]-4-yl((tert-butoxycarbonyl)amino)methyl)-1-acetyl-3-oxoindoline-2-carboxylate
(3l)
(0.095 g, 85% yield) yellow solid. Mp 118–120
°C. IR (neat) ν 3403.5, 3009.2, 2924.3, 1762.3, 1729.9,
1682.6, 1606.6, 1463.2, 1375.3, 1337.6, 1297.4, 1259.5, 1155.0, 1126.5,
750.4, 698.6 cm–1. 1H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 6.4 Hz, 1H), 7.46–7.41
(m, 1H), 7.38–7.34 (m, 4H), 7.30 (dd, J =
6.1, 2.4 Hz, 1H), 7.22 (d, J = 8.0 Hz, 2H), 7.13–7.01
(m, 4H), 6.73 (s, 1H), 6.03 (s, 1H), 3.77 (s, 3H), 2.40 (s, 3H), 1.47
(s, 9H). 13C NMR (101 MHz, CDCl3) δ 194.5,
191.9, 167.8, 165.3, 155.2, 140.6, 140.4, 137.8, 130.3, 128.7, 127.4,
127.3, 126.8, 126.3, 124.9, 124.8, 124.0, 114.7, 101.5, 79.6, 55.7,
53.46, 28.4, 25.7. HRMS (Orbitrap ESI): exact mass calcd for C30H30N2O6Na [M + Na]+: 537.1996. Found: 537.2018. HPLC analysis (DAICEL Chiralpak AS-H), n-hexane/2-PrOH = 80:20, 1 mL/min, 254 nm, major (9.46 min),
minor (14.22 min), ee: 83.25; [α]D20 −48.6 (c =
0.2, CHCl3).

Methyl (R)-1-Acetyl-2-((R)-(4-bromothiophen-2-yl)((tert-butoxycarbonyl)amino)methyl)-3-oxoindoline-2-carboxylate
(3m)
(0.106 g, 95% yield) yellow solid. Mp 118–120
°C. IR (neat) ν 3441.2, 3015.3, 2976.5, 1771.5, 1730.6,
1690.5, 1602.9, 1499.8, 1383.8, 1334.6, 1270.4, 1167.4, 1098.6, 761.9,
650.6 cm–1. 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 7.5 Hz, 1H), 7.62
(t, J = 7.5 Hz, 1H), 7.39 (s, 1H), 7.18 (t, J = 7.5 Hz, 1H), 6.84 (s, 1H), 6.66 (d, J = 9.9 Hz, 2H), 6.22 (d, J = 5.5 Hz, 1H), 3.75 (s,
3H), 2.49 (s, 3H), 1.48 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 193.8, 167.9, 164.7, 155.0, 152.7, 142.2, 138.2,
128.6, 125.5, 125.2, 124.4, 122.1, 114.9, 108.6, 80.1, 74.0, 53.5,
51.9, 28.3, 25.7. HRMS (Orbitrap ESI): exact mass calcd for C22H23BrN2O6SNa [M + Na]+: 545.0340. Found: 545.0368. HPLC analysis (DAICEL Chiralpak
OD-H), n-hexane/2-PrOH = 80:20, 1 mL/min, 254 nm,
major (8.66 min), minor (10.14 min), ee: 98.71; [α]D20 −80.5
(c = 0.15, CHCl3).

Methyl (R)-1-Benzoyl-2-((S)-((tert-butoxycarbonyl)amino)(3-chlorophenyl)methyl)-3-oxoindoline-2-carboxylate
(3n)
(0.086 g, 96% yield) yellow solid. Mp 172–174
°C. IR (neat) ν 3417.7, 3009.8, 2978.1, 1762.2, 1710.0,
1607.3, 1500.8, 1471.1, 1338.6, 1235.4, 1166.2, 1048.1, 752.5, 611.6
cm–1. 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 7.5 Hz, 1H), 7.55 (t, J = 7.5 Hz, 1H), 7.42 (t, J = 7.9 Hz, 2H),
7.24–6.79 (m, 9H), 6.12 (s, 1H), 5.80 (d, J = 8.4 Hz, 1H), 3.82 (s, 3H), 1.47 (s, 9H). 13C NMR (101
MHz, CDCl3) δ 194.2, 167.8, 164.9, 155.2, 153.0,
139.9, 137.1, 134.6, 133.9, 131.8, 129.3, 129.1, 128.1, 127.8, 127.4,
125.3, 124.6, 124.3, 124.1, 115.6, 79.7, 74.2, 55.7, 53.6, 28.4. HRMS
(Orbitrap ESI): exact mass calcd for C29H27ClN2O6Na [M + Na]+: 557.1449. Found: 557.1428.
HPLC analysis (DAICEL Chiralpak AS-H), n-hexane/2-PrOH
= 80:20, 1 mL/min, 254 nm, major (11.54 min), minor (15.97 min), ee:
80.79; [α]D20 −45 (c = 0.7, CHCl3).

Methyl
(R)-1-Acetyl-5-bromo-2-((S)-((tert-butoxycarbonyl)amino)(3-chlorophenyl)methyl)-3-oxoindoline-2-carboxylate
(3o)
(0.070 g, 80% yield) yellow solid. Mp 168–170
°C. IR (neat) ν 3412.0, 3073.3, 2922.5, 1759.5, 1730.5,
1695.3, 1574.7, 1429.8, 1340.1, 1260.5, 1142.6, 1074.1, 771.9, 667.9
cm–1. 1H NMR (400 MHz, CDCl3) δ 7.82 (s, 1H), 7.58 (dd, J = 8.9, 2.1 Hz,
1H), 6.99 (dt, J = 11.1, 8.1 Hz, 4H), 6.86 (d, J = 7.6 Hz, 1H), 6.59 (s, 1H), 5.93 (s, 1H), 3.76 (s, 3H),
2.39 (s, 3H), 1.46 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 192.9, 167.7, 164.5, 155.1, 150.9, 140.5, 139.2,
134.4, 133.8, 130.4, 128.2, 127.4, 125.0, 117.3, 116.2, 80.0, 74.5,
55.5, 53.6, 28.3, 25.5. HRMS (Orbitrap ESI): exact mass calcd for
C24H24BrClN2O6Na [M +
Na]+: 573.0398. Found: 573.0423. HPLC analysis (DAICEL
Chiralpak AS-H), n-hexane/2-PrOH = 80:20, 1 mL/min,
254 nm major (6.57 min), minor (7.35 min), ee: 40; [α]D20 −148 (c = 1.6, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(3-chlorophenyl)methyl)-5-methyl-3-oxoindoline-2-carboxylate
(3p)
(0.090 g, 92% yield) yellow solid. Mp 147–149
°C. IR (neat) ν 3402.6, 3073.3, 2925.5, 1753.6, 1721.5,
1681.1, 1586.5, 1488.5, 1378.9, 1344.7, 1230.6, 1123.6, 1069.3, 770.4,
640.7 cm–1. 1H NMR (400 MHz, CDCl3) δ 7.51 (s, 1H), 7.31 (d, J = 8.1
Hz, 1H), 7.08–6.83 (m, 5H), 6.72 (s, 1H), 5.94 (s, 1H), 3.75
(s, 3H), 2.38 (s, 3H), 2.33 (s, 3H), 1.46 (s, 9H). 13C
NMR (126 MHz, CDCl3) δ 194.1, 167.7, 164.8, 155.2,
150.2, 139.5, 139.2, 134.4, 133.5, 128.9, 127.9, 127.3, 125.1, 124.6,
114.3, 79.7, 74.1, 55.42, 53.4, 28.4, 25.5, 20.4. HRMS (Orbitrap ESI):
exact mass calcd for C25H27ClN2O6Na [M + Na]+: 509.1449. Found: 509.1471. HPLC analysis
(DAICEL Chiralpak OD-H), n-hexane/2-PrOH = 80:20,
1 mL/min, 254 nm major (8.03 min), minor (11.46 min), ee: 90.47; [α]D20 −103 (c = 0.55, CHCl3).

Methyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(3-chlorophenyl)methyl)-5-chloro-3-oxoindoline-2-carboxylate
(3q)
(0.080 g, 85% yield) yellow solid. Mp 166–168
°C. IR (neat) ν 3410.5, 3007.8, 2978.3, 1765.6, 1710.2,
1680.3, 1501.1, 1470.8, 1371.1, 1337.1, 1290.1, 1166.3, 1049.2, 765.0,
686.9 cm–1. 1H NMR (400 MHz, CDCl3) δ 7.66 (s, 1H), 7.44 (dd, J = 8.9,
2.3 Hz, 1H), 7.13–6.91 (m, 4H), 6.86 (d, J = 7.6 Hz, 1H), 6.59 (s, 1H), 5.92 (s, 1H), 3.76 (s, 3H), 2.40 (s,
3H), 1.46 (s, 9H). 13C NMR (101 MHz, CDCl3)
δ 193.0, 167.7, 164.8, 155.3, 150.6, 139.1, 137.0, 133.1, 130.7,
129.8, 128.3, 127.8, 125.6, 124.9, 124.2, 115.5, 79.7, 74.5, 55.0,
53.1, 28.8, 25.4. HRMS (Orbitrap ESI): exact mass calcd for C24H24Cl2N2O6Na
[M + Na]+: 529.0898. Found: 529.0930. HPLC analysis (DAICEL
Chiralpak OD-H), n-hexane/2-PrOH = 80:20, 1 mL/min,
254 nm, major (6.08 min), minor (7.19 min), ee: 57.6; [α]D20 −110 (c = 0.15, CHCl3).

Methyl (R)-4-Acetyl-5-((S)-((tert-butoxycarbonyl)amino)(3-chlorophenyl)methyl)-6-oxo-5,6-dihydro-4H-thieno[3,2-b]pyrrole-5-carboxylate (3r)
(0.092 g, 92% yield) yellow solid. Mp 178–180
°C. IR (neat) ν 3394.7, 3009.9, 2978.5, 1761.5, 1685.5,
1512.2, 1454.9, 1371.6, 1323.3, 1235.9, 1129.7, 989.5, 752.6, 582.4
cm–1. 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 5.1 Hz, 1H), 7.09–6.96
(m, 4H), 6.84 (d, J = 6.5 Hz, 1H), 6.67 (d, J = 5.0 Hz, 1H), 5.95 (d, J = 6.4 Hz, 1H),
3.79 (s, 3H), 2.29 (s, 3H), 1.46 (s, 9H). 13C NMR (101
MHz, CDCl3) δ 184.2, 165.8, 164.4, 163.6, 155.2,
145.5, 139.5, 133.7, 128.9, 128.1, 127.3, 125.2, 122.8, 114.9, 79.7,
79.5, 55.3, 53.5, 28.4, 24.0. HRMS (Orbitrap ESI): exact mass calcd
for C22H23ClN2O6SNa [M
+ Na]+: 501.0881. Found: 501.0880. HPLC analysis (DAICEL
Chiralpak AS-H), n-hexane/2-PrOH = 80:20, 1 mL/min,
254 nm, major (9.71 min), minor (11.68 min), ee: 96.97; [α]D20 −205 (c = 0.55, CHCl3).

Methyl (R)-1-Benzoyl-2-((S)-((tert-butoxycarbonyl)amino)(3-chlorophenyl)methyl)-3-oxo-2,3-dihydro-1H-benzo[f]indole-2-carboxylate (3s)
(0.097 g, 94% yield) yellow solid. Mp 148–150 °C.
IR (neat) ν 3411.9, 3011.5, 2979.6, 1776.7, 1740.5, 1690.8,
1610.5, 1501.6, 1465.7, 1465.7, 1395.6, 1335.7, 1260.5, 1225.6, 1166.5,
1096.4, 776.1, 649.6 cm–1. 1H NMR (500
MHz, CDCl3) δ 8.30 (s, 1H), 7.85 (d, J = 8.1 Hz, 1H), 7.60 (t, J = 7.5 Hz, 1H), 7.53–7.28
(m, 6H), 7.20–7.15 (m, 2H), 7.04–6.96 (m, 4H), 6.18
(s, 1H), 6.04 (s, 1H), 3.81 (s, 3H), 1.49 (s, 9H). 13C
NMR (101 MHz, CDCl3) δ 194.7, 168.4, 165.2, 155.2,
145.6, 140.1, 137.8, 134.8, 134.0, 131.7, 130.3, 130.3, 129.4, 129.0,
128.1, 128.0, 127.9, 127.5, 126.5, 126.1, 125.2, 124.0, 112.3, 79.7,
74.5, 55.6, 53.6, 28.4. HRMS (Orbitrap ESI): exact mass calcd for
C33H29ClN2O6Na [M + Na]+: 607.1606. Found: 607.1631. HPLC analysis (DAICEL Chiralpak
IA), n-hexane/2-PrOH = 80:20, 1 mL/min, 254 nm, major
(6.80 min), minor (7.43 min), ee: 90.27; [α]D20 −150 (c = 0.15, CHCl3).

Ethyl (R)-1-Acetyl-2-((S)-((tert-butoxycarbonyl)amino)(3-chlorophenyl)methyl)-6-chloro-3-oxoindoline-2-carboxylate
(3t)
(0.070 g, 76% yield) pale yellow solid.
Mp 135–137 °C. IR (neat) ν 3309.8, 3006.6, 2968.2,
1765.3, 1711.5, 1688.2, 1502.1, 1471.3, 1372.0, 1337.2, 1291.1, 1164.2,
1049.1, 765.2, 682.8 cm–1. 1H NMR (500
MHz, CDCl3) δ 7.65 (d, J = 8.1 Hz,
1H), 7.11 (dd, J = 8.3, 1.4 Hz, 1H), 7.05 (d, J = 7.7 Hz, 1H), 7.00–6.95 (m, 2H), 6.88 (d, J = 7.6 Hz, 1H), 6.67 (s, 1H), 5.91 (s, 1H), 4.40–4.12
(m, 2H), 2.40 (s, 3H), 1.45 (s, 9H), 1.24 (t, J =
7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ
193.0, 167.7, 164.2, 155.1, 144.7, 133.8, 129.1, 128.2, 127.0, 125.6,
125.0, 114.8, 79.9, 74.7, 62.9, 55.5, 28.4, 25.5, 13.9. HRMS (Orbitrap
ESI): exact mass calcd for C25H26Cl2N2O6Na [M + Na]+: 543.1055. Found:
543.1049. HPLC analysis (DAICEL Chiralpak IA), n-hexane/2-PrOH
= 85:15, 1 mL/min, 254 nm, major (24.55 min), minor (21.23 min), ee:
90.00; [α]D20 −38 (c = 0.3, CHCl3).

Supporting Information Available
The Supporting
Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b02132.Copies of 1H and 13C NMR spectra,
HPLC chromatogram of products, X-ray data for compounds 3h and 3t (PDF)

Products 3h (CIF) (CIF)



Supplementary Material
ao8b02132_si_001.pdf

 ao8b02132_si_002.cif

 ao8b02132_si_003.cif

 The authors declare
no
competing financial interest.

Acknowledgments
G.R.K. thanks UGC, New Delhi, for the award of a fellowship.
==== Refs
References
a Weiner B. ; Szymański W. ; Janssen D. B. ; Minnaard A. J. ; Feringa B. L. 
Recent advances
in the catalytic asymmetric synthesis
of β-amino acids . Chem. Soc. Rev. 
2010 , 39 , 1656 10.1039/b919599h .20419214  b Ashfaq M. ; Tabassum R. ; Ahmad M. M. ; Hassan N. A. ; Oku H. ; Rivera G. 
Enantioselective synthesis of β-amino acids:
A review . Med. Chem. 
2015 , 5 , 7 10.4172/2161-0444.1000278 . c Li L. ; Song B.-A. ; Bhadury P. S. ; Zhang Y.-P. ; Hu D.-Y. ; Yang S. 
Enantioselective synthesis of β-amino
esters bearing a benzothiazole moiety via a Mannich-type reaction
catalyzed by a Cinchona alkaloid derivative . Eur. J. Org. Chem. 
2011 , 4743 10.1002/ejoc.201100351 . d Josephson K. ; Hartman M. C. T. ; Szostak J. W. 
Ribosomal synthesis of unnatural
peptides . J. Am. Chem. Soc. 
2005 , 127 , 11727 10.1021/ja0515809 .16104750  e Cabrele C. ; Martinek T. A. ; Reiserg O. ; Berlicki L. 
Peptides containing β-amino acid patterns: Challenges
and successes in medicinal chemistry . J. Med.
Chem. 
2014 , 57 , 9718 10.1021/jm5010896 .25207470 
a Scott W. L. ; Martynow J. G. ; Huffman J. C. ; O’Donnell M. J. 
Solid-phase
synthesis of multiple classes of peptidomimetics from versatile resin-bound
aldehyde intermediates . J. Am. Chem. Soc. 
2007 , 129 , 7077 10.1021/ja069188y .17503818  b Elashal H. E. ; Sim Y. E. ; Raj M. 
Serine promoted synthesis of peptide
thioester-precursor on solid support for native chemical ligation . Chem. Sci. 
2017 , 8 , 117 10.1039/C6SC02162J .28451155  c Kamath A. ; Ojima I. 
Advances in the chemistry of β-lactam
and its medicinal applications . Tetrahedron 
2012 , 68 , 10640 10.1016/j.tet.2012.07.090 .23264702  d Jamieson A. G. ; Boutard N. ; Sabatino D. ; Lubell W. D. 
Peptide scanning
for studying structure-activity relationships in drug discovery . Chem. Biol. Drug Des. 
2013 , 81 , 148 10.1111/cbdd.12042 .23253136 
a The Chemistry of Indoles ; Sundberg R. J.  , Ed.; Academic
press : New York , 1996 .b Yap W.-S. ; Gan C.-Y. ; Low Y.-Y. ; Choo Y.-M. ; Etoh T. ; Hayashi M. ; Komiyama K. ; Kam T.-S. 
Grandilodines A-C, biologically active indole alkaloids
from Kopsiagrandifolia . J. Nat. Prod. 
2011 , 74 , 1309 10.1021/np200008g .21428274  c Umehara A. ; Ueda H. ; Tokuyama H. 
Total syntheses of Leuconoxine, Leuconodine
B, and Melodinine E by oxidative cyclic aminal formation and diastereoselective
ring-closing metathesis . Org. Lett. 
2014 , 16 , 2526 10.1021/ol500903e .24754345  d Bass P. D. ; Gubler D. A. ; Judd T. C. ; Williams R. M. 
Mitomycinoid alkaloids:
Mechanism of action, biosynthesis, total syntheses, and synthetic
approaches . Chem. Rev. 
2013 , 113 , 6816 10.1021/cr3001059 .23654296  e Lim K.-H. ; Kam T.-S. 
New indole alkaloids
from Kopsia. Alkaloid variation in Kopsiasingapurensis . Helv. Chim. Acta 
2007 , 90 , 31 10.1002/hlca.200790018 . f Xu Z. ; Wang Q. ; Zhu J. 
Total syntheses of
(−)-Mersicarpine, (−)-Scholarisine G, (+)-Melodinine
E, (−)-Leuconoxine, (−)-Leuconolam, (−)-Leuconodine
A, (+)-Leuconodine F, and (−)-Leuconodine C: Self-induced diastereomeric
anisochronism (SIDA) phenomenon for Scholarisine G and Leuconodines
A and C . J. Am. Chem. Soc. 
2015 , 137 , 6712 10.1021/jacs.5b03619 .25946614  g Steven A. ; Overman L. E. 
Total synthesis
of complex cyclotryptamine alkaloids: Stereocontrolled construction
of quaternary carbon stereocenters . Angew. Chem.,
Int. Ed. 
2007 , 46 , 5488 10.1002/anie.200700612 . h Pearson W. H. ; Mi Y. ; Lee I. Y. ; Stoy P. 
Total synthesis of the Kopsialapidilecta
alkaloid (±)-Lapidilectine B . J. Am. Chem.
Soc. 
2001 , 123 , 6724 10.1021/ja016007d .11439072  i Guengerich F. P. ; Sorrells J. L. ; Schmitt S. ; Krauser J. A. ; Aryal P. ; Meijer L. 
Generation of new protein kinase inhibitors utilizing
cytochrome p450 mutant enzymes for indigoid synthesis . J. Med. Chem. 
2004 , 47 , 3236 10.1021/jm030561b .15163202  j Petkovic M. ; Nasufovic V. ; Djukanovic D. ; Vujosevic Z. T. ; Jadranin M. ; Matovic R. ; Savic V. 
Cyclative
cascades of allenamides derived from amino acids: Synthesis of annulated
indoxyl derivatives . Eur. J. Org. Chem. 
2016 , 1279 10.1002/ejoc.201600067 . k Patel P. ; Reddy B. N. ; Ramana C. V. 
The synthesis of
the central tricyclic core of the isatisine A: Harmonious orchestration
of [metal]-catalyzed reactions in a sequence . Tetrahedron 
2014 , 70 , 510 10.1016/j.tet.2013.11.026 .
a Tan C.-J. ; Di Y.-T. ; Wang Y.-H. ; Zhang Y. ; Si Y.-K. ; Zhang Q. ; Gao S. ; Hu X.-J. ; Fang X. ; Li S.-F. ; Hao X.-J. 
Three new
indole
alkaloids from Trigonostemon lii . Org. Lett. 
2010 , 12 , 2370 10.1021/ol100715x .20405956  b Han S. ; Movassaghi M. 
Concise total synthesis and stereochemical revision
of all (−)-trigonoliimines . J. Am. Chem.
Soc. 
2011 , 133 , 10768 10.1021/ja204597k .21667943  c Qi X. ; Bao H. ; Tambar U. K. 
Total synthesis of (±)-Trigonoliimine C via oxidative
rearrangement of an unsymmetrical bis-tryptamine . J. Am. Chem. Soc. 
2011 , 133 , 10050 10.1021/ja203960b .21671591  d Reddy B. N. ; Ramana C. V. 
A modular total synthesis of (±)-trigonoliimine
C . Chem. Commun. 
2013 , 49 , 9767 10.1039/c3cc45512b . e Han S. ; Morrison K. C. ; Hergenrother P. J. ; Movassaghi M. 
Total synthesis, stereochemical assignment, and biological
activity of all known (−)-trigonoliimines . J. Org. Chem. 
2014 , 79 , 473 10.1021/jo4020358 .24127681  f Liu S. ; Hao X.-J. 
A biomimetic synthesis of the skeleton
of trigonoliimine C . Tetrahedron Lett. 
2011 , 52 , 5640 10.1016/j.tetlet.2011.08.087 .
a Wu P.-L. ; Hsu Y.-L. ; Jao C.-W. 
Indole
alkaloids
from Cephalanceropsisgracilis . J. Nat. Prod. 
2006 , 69 , 1467 10.1021/np060395l .17067163  b Dend Z. ; Peng X. ; Huang P. ; Jiang L. ; Ye D. ; Liu L. 
A multi-functionalized strategy of indoles to C2-quaternary indolin-3-ones
via a TEMPO/Pd-catalyzed cascade process . Org.
Biomol. Chem. 
2017 , 15 , 442 10.1039/C6OB02285E .27924331  c Blunt J. W. ; Copp B. R. ; Keyzers R. A. ; Munro M. H. G. ; Prinsep M. R. 
Marine
natural products . Nat. Prod. Rep. 
2014 , 31 , 160 10.1039/c3np70117d .24389707  d Baran P. S. ; Corey E. J. 
A short synthetic route to (+)-austamide, (+)-deoxyisoaustamide,
and (+)-hydratoaustamide from a common precursor by a novel palladium-mediated
indole → dihydroindoloazocine Cyclization . J. Am. Chem. Soc. 
2002 , 124 , 7904 10.1021/ja026663t .12095326 
a Liu J.-F. ; Jiang Z.-Y. ; Wang R.-R. ; Chen Y.-T. ; Zheng J.-J. ; Zhang X.-M. ; Ma Y.-B. 
Isatisine
A, a novel
alkaloid with an unprecedented skeleton from leaves of Isatisindigotica . Org. Lett. 
2007 , 9 , 4127 10.1021/ol701540y .17850153  b Karadeolian A. ; Kerr M. A. 
Total synthesis of (+)-isatisine
A . Angew. Chem., Int. Ed. 
2010 , 49 , 1133 10.1002/anie.200906632 . c Lee J. ; Panek J. 
S.Total synthesis of
the Hsp90 inhibitor Geldanamycin . Org. Lett. 
2011 , 13 , 502 10.1021/ol102848w .21188973  d Kumar C. V. S. ; Puranik V. G. ; Ramana C. V. 
InCl3-mediated addition
of indole to isatogens: An expeditious synthesis of 13-deoxy-isatisine
A . Chem. - Eur. J. 
2012 , 18 , 9601 10.1002/chem.201103604 .22763920  e Gu W. ; Zhang Y. ; Hao X.-J. ; Yang F. M. ; Sun Q.-Y. ; Morris-Natschke S. L. ; Lee K.-H. ; Wang Y.-H. ; Long C.-L. 
Indole alkaloid
glycosides from the aerial parts of Strobilanthescusia . J. Nat. Prod. 
2014 , 77 , 2590 10.1021/np5003274 .25427242 
a Chen S. ; Wang Y. ; Zhou Z. 
Organo-catalyzed
asymmetric
Michael addition of 1-acetylindolin-3-ones to β,γ-unsaturated
α-ketoesters: An access to chiral indolin-3-ones with two adjacent
tertiary stereogenic centers . J. Org. Chem. 
2016 , 81 , 11432 10.1021/acs.joc.6b02070 .27787996  b Chen T.-G. ; Fang P. ; Hou X.-L. ; Dai L.-X. 
Palladium-Catalyzed
asymmetric allylic alkylation reaction of 2-monosubstituted indolin-3-ones . Synthesis 
2015 , 47 , 134 10.1055/s-0034-1379043 . c Yin Q. ; You S.-L. 
Chiral phosphoric acid-catalysed
Friedel–Crafts alkylation reaction of indoles with racemic
spiro-indolin-3-ones . Chem. Sci. 
2011 , 2 , 1344 10.1039/c1sc00190f . d Guo J. ; Lin Z.-H. ; Chen K.-B. ; Xie Y. ; Chen A. S. C. ; Weng J. ; Lui G. 
Asymmetric amination of 2-substituted
indolin-3-ones catalyzed by natural cinchona alkaloids . Org. Chem. Front. 
2017 , 4 , 1400 10.1039/C7QO00129K . e Liu Y.-Z. ; Zhang J. ; Xu P.-F. ; Luo Y.-C. 
Organocatalytic
asymmetric Michael addition of 1-acetylindolin-3-ones to α,β-unsaturated
aldehydes: Synthesis of 2-substituted indolin-3-ones . J. Org. Chem. 
2011 , 76 , 7551 10.1021/jo201123p .21812470  f Jin C.-Y. ; Wang Y. ; Liu Y.-Z. ; Shen C. ; Xu P.-F. 
Organocatalytic asymmetric Michael addition of oxindoles to nitroolefins
for the synthesis of 2,2-disubstituted oxindoles bearing adjacent
quaternary and tertiary stereocenters . J. Org.
Chem. 
2012 , 77 , 11307 10.1021/jo301886j .23167772  g Zhao Y.-L. ; Wang Y. ; Cao J. ; Liang Y.-M. ; Xu P.-F. 
Organocatalytic
asymmetric Michael-Michael cascade for the construction of highly
functionalized N-fused piperidino-indoline derivatives . Org. Lett. 
2014 , 16 , 2438 10.1021/ol5008185 .24734923  h Mahajan S. ; Chauhan P. ; Loh C. C. J. ; Uzungelis S. ; Raabe G. ; Enders D. 
Organocatalytic asymmetric domino
Michael/Henry reaction of indolin-3-ones with O-formyl-β-nitrostyrenes . Synthesis 
2015 , 47 , 1024 10.1055/s-0034-1379943 .26722133  i Sun W. ; Hong L. ; Wang R. 
Chem. - Eur. J. 
2011 , 17 , 6030 10.1002/chem.201100144 .21503993  j Ni Q. ; Raabe G. ; Enders D. ; Song X. 
N-Heterocyclic
carbene-catalyzed enantioselective annulation of indolin-3-ones with
bromoenals . Chem. - Asian J. 
2014 , 9 , 1535 10.1002/asia.201402052 .24729588  k Rueping M. ; Raja S. ; Nunez A. 
Asymmetric
Brønsted acid-catalyzed Friedel–Crafts reactions of indoles
with cyclic imines: Efficient generation of nitrogen substituted quaternary
carbon centers . Adv. Synth. Catal. 
2011 , 353 , 563 10.1002/adsc.201000952 . l Nakamura S. ; Matsuda N. ; Ohara M. 
Organocatalytic enantioselective
aza-Friedel-Crafts reaction of cyclic ketimines with pyrroles using
imidazoline-phosphoric acid catalysts . Chem.
- Eur. J. 
2016 , 22 , 1 10.1002/chem.201601573 . m Parra A. ; Alfaro R. ; Marzo L. ; Moreno-Carrasco A. ; Ruano J. L. G. ; Alema J. 
Enantioselective aza-Henry reactions
of cyclic α-carbonyl ketimines under bifunctional catalysis . Chem. Commun. 
2012 , 48 , 9759 10.1039/c2cc34053d . n Yin Q. ; You S.-L. 
Chiral phosphoric acid-catalysed
Friedel–Crafts alkylation reaction of indoles with racemic
spiro-indolin-3-ones . Chem. Sci. 
2011 , 2 , 1344 10.1039/c1sc00190f . o Schendera E. ; Lerch S. ; Drathen T. V. ; Unkel L.-N. ; Brasholz M. 
Phosphoric
acid catalyzed 1,2-rearrangements of 3-hydroxyindolenines to indoxyls
and 2-oxindoles: Reagent-controlled regioselectivity enabled by dual
activation . Eur. J. Org. Chem. 
2017 , 22 , 3134 10.1002/ejoc.201700085 . p Kumar C. V. S. ; Puranik V. G. ; Ramana C. V. 
InCl3-mediated addition
of indole to isatogens: An expeditious synthesis of 13-deoxy-isatisine
A . Chem. - Eur. J. 
2012 , 18 , 9601 10.1002/chem.201103604 .22763920 
a Liu R.-R. ; Ye S.-C. ; Lu C.-J. ; Gao G.-L. ; Zhuang J.-R. ; Jia Y.-X. 
Dual catalysis for the redox annulation
of nitroalkynes with indoles: Enantioselective construction of indolin-3-ones
bearing quaternary stereocenters . Angew. Chem.,
Int. Ed. 
2015 , 54 , 11205 10.1002/anie.201504697 . b Gajulapalli V. P. R. ; Jafari E. ; Kundu D. S. ; Mahajan S. ; Peuronen A. ; Rissanen K. ; Enders D. 
Organocatalytic asymmetric synthesis
of 2,3′-connected bis-indolinones by Mannich reactions of N-acetylindolin-3-ones with isatin N-Boc-ketimines . Synthesis 
2017 , 49 , 4986 10.1055/s-0036-1590823 . c Rueping M. ; Rasappan R. ; Raja S. 
Asymmetric proline-catalyzed
addition of aldehydes to 3H-indol-3-ones: Enantioselective
synthesis of 2,3-dihydro-1H-indol-3-ones with quaternary
stereogenic centers . Helv. Chim. Acta 
2012 , 95 , 2296 10.1002/hlca.201200498 . d Yan W. ; Wang D. ; Feng J. ; Li P. ; Zhao D. ; Wang R. 
Synthesis of N-alkoxycarbonyl ketimines derived
from isatins and their application in enantioselective synthesis of
3-aminooxindoles . Org. Lett. 
2012 , 14 , 2512 10.1021/ol3007953 .22540839  e Zhao K. ; Shu T. ; Jia J. ; Raabe G. ; Enders D. 
An organocatalytic Mannich/denitration
reaction for the asymmetric synthesis of 3-ethylacetate-substitued
3-amino-2-oxindoles: Formal synthesis of AG-041R . Chem. - Eur. J. 
2015 , 21 , 3933 10.1002/chem.201406422 .25630891  f Hara N. ; Nakamura S. ; Sano M. ; Amura R. ; Funahashi Y. ; Shibata N. 
Enantioselective synthesis of AG-041R
by using N-heteroarenesulfonyl cinchona alkaloid
amides as organocatalysts . Chem. - Eur. J. 
2012 , 18 , 9276 10.1002/chem.201200367 .22736544  g Liu Y.-L. ; Zhou J. 
Organocatalytic asymmetric cyanation of isatin derived N-Boc-ketoimines . Chem. Commun. 
2013 , 49 , 4421 10.1039/C2CC36665G .
a Cai X.-H. ; Xie B. 
Recent advances on organo-catalysed
asymmetric Mannich reactions . ARKIVOC 
2013 , 264 10.3998/ark.5550190.p007.839 . b Ishitani H. ; Ueno M. ; Kobayashi S. 
Enantioselective
Mannich-type reactions using a novel chiral zirconium catalyst for
the synthesis of optically active β-amino acid derivatives . J. Am. Chem. Soc. 
2000 , 122 , 8180 10.1021/ja001642p . c Zhuang W. ; Saaby S. ; Jørgensen K. A. 
Direct
organocatalytic enantioselective Mannich reactions of ketimines: An
approach to optically active quaternary α-amino acid derivatives . Angew. Chem., Int. Ed. 
2004 , 43 , 4476 10.1002/anie.200460158 . d Verkade J. M. M. ; Hemert L. J. C. V. ; Quaedflieg P. J. L. M. ; Rutjes F. P. J. T. 
Organo-catalysed asymmetric Mannich
reactions . Chem. Soc. Rev. 
2008 , 37 , 29 –41 . 10.1039/B713885G .18197331  e Córdova A. 
The direct
catalytic asymmetric Mannich reaction . Acc.
Chem. Res. 
2004 , 37 , 102 10.1021/ar030231l .14967057  f Trost B. M. ; Saget T. ; Hung C.-I. 
Direct catalytic asymmetric Mannich
reactions for the construction of quaternary carbon stereocenters . J. Am. Chem. Soc. 
2016 , 138 , 3659 10.1021/jacs.6b01187 .26952276 
a Yarlagadda S. ; Reddy C. R. ; Ramesh B. ; Kumar G. R. ; Sridhar B. ; Reddy B. V. S. 
Organocatalytic
enantioselective Michael addition of 3-indolinone-2-carboxylates to
maleimides . Eur. J. Org. Chem. 
2018 , 1364 10.1002/ejoc.201701670 . b Yarlagadda S. ; Sridhar B. ; Reddy B. V. S. 
Oxidative asymmetric
aza-Friedel–Crafts alkylation of indoles with 3-indolinone-2-carboxylates
catalyzed by a BINOL phosphoric acid and promoted by DDQ . Chem. - Asian J. 
2018 , 1327 10.1002/asia.201800300 .29575703  c Yarlagadda S. ; Sankaram G. S. ; Sridhar B. ; Reddy B. V. S. 
Asymmetric
Robinson annulation of 3-indolinone-2-carboxylates with cyclohexenone:
Access to chiral bridged tricyclic hydrocarbazole . Org. Lett. 
2018 , 20 , 4195 10.1021/acs.orglett.8b01575 .29975069 
CCDC
1842015 and 1887364 contains supplementary Crystallographic data for
the structures 3h and 3t. These data can
be obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html.
a Yarlagadda S. ; Ramesh B. ; Reddy C. R. ; Srinivas L. ; Sridhar B. ; Reddy B. V. S. 
Organocatalytic
enantioselective amination of 2-substituted indolin-3-ones: A strategy
for the synthesis of chiral α-hydrazino esters . Org. Lett. 
2017 , 19 , 170 10.1021/acs.orglett.6b03473 .28009174  b Wang Q. ; Leutzsch M. ; Gemmeren M. V. ; List B. 
Disulfonimide-catalyzed
asymmetric synthesis of β-amino esters directly from N-Boc-amino sulfones . J. Am. Chem.
Soc. 
2013 , 135 , 15334 10.1021/ja408747m .24090068  c Blom J. ; Vidal-Albalat A. ; Jørgensen J. ; Barløse C. L. ; Jessen K. S. ; Iversen M. V. ; Jørgensen K. A. 
Directing
the activation of Donor–Acceptor cyclopropanes towards stereoselective
1,3-dipolar cycloaddition reactions by Brønsted base catalysis . Angew. Chem., Int. Ed. 
2017 , 56 , 11831 10.1002/anie.201706150 .

